TPR is a prognostic biomarker and potential therapeutic target associated with immune infiltration in hepatocellular carcinoma
Article in Molecular and Clinical Oncology (February 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Article in Molecular and Clinical Oncology (February 2024)
Article in hLife (January 2024)
Article in Brazilian Journal of Otorhinolaryngology (March 2023)